Joël Crouzet
Chief Executive Officer at Ermium Therapeutics SAS
Profile
Joël Crouzet was the founder of Minka Therapeutics SA, which was founded in 2008, where he held the title of Chief Executive & Scientific Officer from 2011 to 2014.
He is also the founder of Ermium Therapeutics SAS, which is founded in 2019, where he currently holds the title of Chief Executive Officer.
Dr. Crouzet's former jobs include being the Chief Executive Officer of INSERM Transfert SA, Departmental Director at Rhone Poulenc Rorer from 1990 to 1996, and Research Director at NeuroTECH SA. He received a doctorate degree from Institut National Agronomique Paris-Grignon.
Joël Crouzet active positions
| Companies | Position | Start |
|---|---|---|
Ermium Therapeutics SAS
 Ermium Therapeutics SAS BiotechnologyHealth Technology Ermium Therapeutics SAS is a biotechnology company, which develops therapies for auto-immune diseases. It specializes in conditions such as systemic lupus erythematous, multiple sclerosis, and rheumatoid arthritis. The company was founded by Joël Crouzet and Jean-Philippe Herbeuval in June 2019 and is headquartered in Paris, France. | Chief Executive Officer | 2019-06-30 |
Former positions of Joël Crouzet
| Companies | Position | End |
|---|---|---|
INSERM Transfert SA
 INSERM Transfert SA Investment ManagersFinance INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France. | President | 2008-08-31 |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | - |
NeuroTECH SA
 NeuroTECH SA Medical SpecialtiesHealth Technology Neurotech's founders have many years of experience in the development of innovative (cochlear) implants and implantable recording/stimulation electrodes. Neurotech SA was incorporated in 1996 to design, develop, manufacture and market active implantable medical devices for the treatment of debilitating disorders by neurostimulation. The Company, in the heart of Europe near Brussels, has since acquired significant expertise in applied biomedical technology. | Chief Tech/Sci/R&D Officer | - |
Minka Therapeutics SA
 Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Chief Executive Officer | - |
Training of Joël Crouzet
| Institut National Agronomique Paris-Grignon | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
INSERM Transfert SA
INSERM Transfert SA Investment ManagersFinance INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France. | Finance |
NeuroTECH SA
NeuroTECH SA Medical SpecialtiesHealth Technology Neurotech's founders have many years of experience in the development of innovative (cochlear) implants and implantable recording/stimulation electrodes. Neurotech SA was incorporated in 1996 to design, develop, manufacture and market active implantable medical devices for the treatment of debilitating disorders by neurostimulation. The Company, in the heart of Europe near Brussels, has since acquired significant expertise in applied biomedical technology. | Health Technology |
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Health Technology |
Ermium Therapeutics SAS
Ermium Therapeutics SAS BiotechnologyHealth Technology Ermium Therapeutics SAS is a biotechnology company, which develops therapies for auto-immune diseases. It specializes in conditions such as systemic lupus erythematous, multiple sclerosis, and rheumatoid arthritis. The company was founded by Joël Crouzet and Jean-Philippe Herbeuval in June 2019 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Joël Crouzet
